---
title: "Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288323253.md"
description: "Pulmonx Corporation, a leading provider of minimally invasive lung disease treatments, announced on June 1, 2026, that it granted equity awards to 17 new employees who were hired in the first half of the year. The awards were issued under the 2025 Inducement Plan and approved by the Compensation Committee of the Company’s Board of Directors. This move, in compliance with Nasdaq Listing Rule 5635(c)(4), was intended to attract and retain top talent. Each award is contingent upon the Inducement Plan's terms and the corresponding grant agreements."
datetime: "2026-06-01T20:08:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288323253.md)
  - [en](https://longbridge.com/en/news/288323253.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288323253.md)
---

# Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Pulmonx Corporation, a leading provider of minimally invasive lung disease treatments, announced on June 1, 2026, that it granted equity awards to 17 new employees who were hired in the first half of the year. The awards were issued under the 2025 Inducement Plan and approved by the Compensation Committee of the Company’s Board of Directors. This move, in compliance with Nasdaq Listing Rule 5635(c)(4), was intended to attract and retain top talent. Each award is contingent upon the Inducement Plan's terms and the corresponding grant agreements.

### Related Stocks

- [LUNG.US](https://longbridge.com/en/quote/LUNG.US.md)

## Related News & Research

- [aTyr Pharma submits Phase 3 efzofitimod trial protocol to FDA for pulmonary sarcoidosis study](https://longbridge.com/en/news/295273060.md)
- [Worried the S&P 500 Bull Run Is Getting Old? Top Strategist Says 3.8 Years Is No Reason to Sell: 'Usually Last Many, Many More Years'](https://longbridge.com/en/news/295404538.md)
- [Seaport Research Partners Reaffirms "Neutral" Rating for FOX (NASDAQ:FOX)](https://longbridge.com/en/news/295241274.md)
- [Blue Owl Capital (OWL) Is Up 20.9% After Beating Q2 2026 Targets And Closing €1.6B Fund – Has The Bull Case Changed?](https://longbridge.com/en/news/295104920.md)
- [CK Hutchison Holdings (SEHK:1) Gets Panama Relief, Is The Stock Still Undervalued?](https://longbridge.com/en/news/295336439.md)